All News

An expert discusses ways to complement cancer treatment and potentially improve outcomes.

“The lack of concern is significant because some survivors may not engage in risk-reduction activities, such as recommended screening tests and healthy behaviors,” Todd Gibson, Ph.D.

A newly developed blood test may identify people at an increased risk for lung cancer, even if they are not within the screening guidelines.

My heart seeks joy. My life is joyful, full of light. And I know trauma can live in the light, I have seen it and lived it.

The health care experts call it financial toxicity. I call it an agonizing, stress-inducing, horrifying choice between financial ruin and treatment of a life-threatening disease.

Understanding how melanoma spreads can lead to better outcomes. That's what researchers at UCSF aimed to do.

While we are more than the sum of our genes, genetic information is useful as we contemplate health issues, including cancer.

Thanks to two pilot programs, the FDA was able to more efficiently approve Kisqali for certain patients with advanced breast cancer.

"Scanxiety" is common in people with cancer, but is particularly prevalent in those with lung cancer, according to a recent survey.

While there are known risk factors of developing acute myeloid leukemia (AML) – such as a myelodysplastic syndrome diagnosis and receiving chemotherapy and radiotherapy – a diagnosis can still stun and individual. But researchers at Weill Cornell Medicine and New York-Presbyterian recently discovered a genomic pre-malignant biomarker of the disease that can identify people who are at a greater risk for AML.

When I look in the mirror, I see that I am the byproduct of multiple surgeries. Sometimes, I feel as if I look like shark bait.

Researchers reviewed the cases of more than 20,000 women – some who went on to develop ovarian cancer, and some who didn’t – and found that there was a small, but statistically significant increase in ovarian cancer incidence in women who reported having severe menstrual pain.

Instead of feeling helpless, there are ways you can assist your loved one in navigating cancer. This post offers helpful tips to guide you along the way.

Many questions still remain in the treatment of localized bladder cancer, like which patients are best suited to receive neoadjuvant (pre-surgery) chemotherapy – a procedure that could be beneficial to many, but comes with increased toxicity.

A little smiling action, as opposed to frowning or grimacing, might just help combat the cancer fears and maybe even make you feel a bt better, too.

Words matter when you talk about cancer.

July is UV Safety Awareness Month. See three tips on how to protect yourself from harmful UV rays, which are the leading cause of skin cancer.

Has anyone thought about a career change since having cancer?

Researchers from Duke Cancer Institute in Durham, North Carolina, developed a genetically modified poliovirus to attack the rare but aggressive brain cancer by directly injecting the virus into the tumor.

Can cancer actually lift an individual out of the "rabbit hole" of despair?

A national survey demonstrated shared feelings across all blood cancer types about treatment options and their side effects, as well as other social, financial and emotional aspects.

What if there were some way to identify gene mutations causing the cell to behave as a cancer and then, with a medication, undo the effects of the errant gene? This is the basis of personalized medicine.

In spending so many hours online, I came to see that much of what I was reading was opinions and, in fact, not facts at all.

The Food and Drug Administration (FDA) granted a priority review to Keytruda (pembrolizumab) for the treatment of previously treated patients with advanced hepatocellular carcinoma (HCC).

The FDA approved Opdivo plus Yervoy to treat a certain subset of patients with metastatic colorectal cancer.

While celebrating the Fourth of July, perhaps it is time to celebrate our independence from cancer fears as well.

The majority of adolescent and young adult (AYA) patients who are diagnosed with cancer are expected to live past the five-year mark, though survival and health outcomes seem to differ by disease type, according to recent research published in the journal Cancer.